ALICE BALL AWARD

Jenny Low, MBBS, MRCP, MPH

Dr. Jenny Low is a senior consultant with the Department of Infectious Diseases in Singapore General Hospital and Professor in the Emerging Infectious Diseases Programme at Duke-NUS Medical School. Concurrently, she is the Co-Director of Viral Research and Experimental Medicine Centre@ SingHealth Duke-NUS (ViREMiCS) in the SingHealth/Duke-NUS Academic Medical Centre and Deputy Clinical and Scientific Director at the SingHealth Investigational Medicine Unit (IMU). She is also the Vice-Chair (research) for the Medicine Academic Clinical Programme at SingHealth/Duke-NUS Academic Medical Centre. Dr Jenny Low’s expertise is on conducting proof-of -concept, first-in-human therapeutics (including biologics and mRNA) using innovative trial designs and leveraging on molecular signatures to address emerging and re-emerging infectious diseases. She hopes to define clinical trial endpoints using objective molecular markers rather than subjective clinical observations in early phase trials and to develop the regulatory acceptance of molecular endpoints to augment the informativeness of early phase clinical trials.

About the Award

The Alice Ball Excellence Award is presented annually by the International Society for Antiviral Research (ISAR) at the International Conference on Antiviral Research. The award recognizes a scientist who exemplifies the values of ISAR and has demonstrated outstanding resilience in overcoming individual or collective challenges in the pursuit of antiviral research and development. The award reflects ISAR’s commitment to ensuring that antiviral research and development reaches, benefits, and includes people from all backgrounds and communities. The award includes a $3,000 cash award and up to $2,500 for administrative fees and travel support (varies based on awardee location). The recipient will also deliver a presentation at the annual conference.

Award Criteria

The recipient should be a scientist who has demonstrated:• Significant contributions to antiviral research and recognition within their field for high-impact scientific work, as evidenced by the quality and impact of publications, patents, products, policies, presentations, or other contributions.

Nominations

Nominations must be submitted by a member in good standing of ISAR and should include:

Nominations are reviewed by the ISAR Awards Committee, which selects the recipient. The ISAR President will notify the recipient and nominator of the selection. The award is presented at the next International Conference on Antiviral Research, where the recipient will deliver a presentation as part of the award ceremony.

Previous Recipients